BLB (BLBLIMITED)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• P/B of 0.86: buying ₹20.72 book value at ₹17.75, a clear margin of safety
• Zero debt (D/E 0.00) and Piotroski F-Score 7/9 indicate a financially solid balance sheet
• ROE of 24.04% with a P/E of 3.61 implies substantial earnings yield relative to price
• Sales and profit growth of 277.92% and 274.90% show strong recent momentum

Concerns

• ROCE of 6.58% is far below ROE of 24.04%, creating doubt about the quality and sustainability of reported earnings
• Latest quarter net margin is only about 3.25% (₹9 Cr profit on ₹277 Cr sales), so growth can be low-quality or volatile
• Dividend yield is 0.00%, leaving minority shareholders dependent on management's capital allocation
• As an investment company, BLB lacks a durable competitive moat and may be exposed to capital market swings

AI Analysis

Let me start with what I like. At ₹17.75, BLB trades at a market capitalization of just ₹94 Cr, while book value stands at ₹20.72 per share. That means I am buying assets worth ₹1 for roughly 86 paise. With a P/E of 3.61, the market is pricing in very little earnings power. The balance sheet is clean: debt/equity is 0.00, and the Piotroski F-Score of 7/9 suggests the financial position is improving. ROE of 24.04% is genuinely impressive if it is sustainable. But I must slow down. This is an investment company, not a business with a wide moat. A 24% ROE sitting next to a 6.58% ROCE tells me the quality of operating capital returns is far weaker than the headline number; I cannot explain that gap, and Buffett would demand an explanation. Sales growth of 277.92% and profit growth of 274.90% look wonderful, but they are exactly the kind of numbers that can reverse quickly in an investment company. The latest quarter shows ₹277 Cr of sales and only ₹9 Cr of net profit — a thin margin of about 3.2%. With no dividend, my return as a minority shareholder depends entirely on management's capital allocation and the whims of capital markets. In Graham's language, this is a bargain in assets, not necessarily a wonderful franchise. The lack of debt and low price-to-book give me some protection, but the absence of a dividend and the opaque earnings engine demand caution. I would keep a small position, watch quarterly profit consistency, and not mistake a 0.01 PEG for safety. This is an asset play with a growth label, not a compounded business I can trust forever.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer